January 16, 2023 - January 19, 2023

Aristo Bio-Tech and Lifescience IPO Review & Recommendations

Dilip Davda has given "May Apply" recommendation to Aristo Bio-Tech and Lifescience IPO.

Aristo Bio-Tech and Lifescience IPO Review Summary from brokers and analysts

Review By	Apply	May Apply	Neutral	Avoid	Not Rated
Count	0	1	0	0	0
%	0.00	100.00	0.00	0.00	0.00

Aristo Bio-Tech and Lifescience IPO Analysis By Brokers/Analysts

Reviewer	Recommendation	Past Reviews
Dilip Davda	May Apply

Aristo Bio-Tech and Lifescience IPO Review by Dilip Davda (May apply)

[Dilip Davda] Based on its super earnings for H1 of FY23, the IPO is fully priced discounting all near-term positives. The sustainability of such margins going forward is a major concern. The segment too is becoming crowded and highly competitive. Post-IPO small paid-up equity also indicates longer gestation for migration to the main board. Well-informed investors may park funds with a long-term perspective. Read detail review...

Aristo Bio-Tech and Lifescience IPO Review by Members

Aristo Bio-Tech and Lifescience IPO Reviews, analysis and views by popular members. Read Aristo Bio-Tech and Lifescience Limited IPO reviews by retail investors to find recommended ipo to buy.

Post Recommendation Manage Your IPO Reviews

Aristo Bio-Tech and Lifescience IPO Review Summary by Members

Review By	Apply	May Apply	Neutral	Avoid
Count	3	0	1	2
%	50.00	0.00	16.67	33.33

Member	Review
Gaurav DD dimer IPO Mentor (1200+ Posts, 400+ Likes)	Apply for Listing Gain at Cut-off Price Going with 21 Lots. If anyone wants to join, Can join. January 16, 2023 6:46:06 PM
ipopraveen	Neutral the issue is fully priced in peer competitors like Dhanuka have 12 - 13% PAT margin whereas aristo is having PAT margin of 1-2% January 13, 2023 3:52:29 PM
IPOse Dukhi Atma (200+ Posts)	Avoid Revenue is decreasing over the years. Also fake promotion is going on in CG messages. So sounds fishy and risky to me. IPO price is costly. I would have subscribed if IPO prize was below 30. January 12, 2023 7:54:10 PM
CAhsBlr	Avoid It is a fully priced IPO. SME is very risky and hence I apply to only those IPOs where more money is left on table. Return of capital is more important than return on capital. 2 January 11, 2023 10:10:48 AM
Loy Hus	Apply for Listing Gain at Cut-off Price Looks promising American, Chinese, Govt customers. January 11, 2023 1:04:37 PM
RANJAN NK	Apply for Listing Gain at Upper Price Band Subscribe for huge returns 1 January 10, 2023 3:19:09 PM

Post Recommendation Manage Recommendations

Note:

The recommendations or analysis of public issues posted above expresses the views of its author and does not represent the views of Chittorgarh.com or its staff.
We reserve the right to remove any objectionable post without providing a reason.

1 Comments

1. Jaffar Link|January 10, 2023 5:37:07 PM

How is overall company performing??? Is it good to invest

1.1. Mangesh Padwal Link|February 16, 2023 7:37:00 PM

Yes.......... ... .. ..... .... .... .... .... .

1.2. Mangesh Padwal Link|February 16, 2023 7:37:51 PM

Yes.......... ... .. ..... .... .... .... .... .